HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

QuickSee Handheld Autorefractor Can Dramatically Increase Access to Eyeglasses According to a Study

The device is designed to reduce global uncorrected refractive error.

Surfacide Peer-Reviewed Study: Confirms UV-C Extremely Effective in Killing SARS-CoV-2 On Surfaces and Air in Environments

The study was led by Dr. Randy Loftus, MD, an Associate Professor of Anesthesiology and Critical Care Medicine at University of Iowa Hospital and Clinics, and Dr. Franklin Dexter, MD, PhD, University of Iowa Professor in the Department of Anesthesia.

CarThera Reports Preclinical Results in the Testing of the Combination of SonoCloud® Technology with Immunotherapies

The goal of the preclinical work was to investigate the following: to see if low-intensity pulsed ultrasound could enhance the therapeutic efficacy of anti-PD-1 in C57BL/6 mice – bearing intracranial GL261 gliomas; epidermal growth factor receptor variant III (EGFRvIII) specific chimeric antigen receptor (CAR) T cells within NSG mice with established EGFRvIII-U87 gliomas (epidermal growth factor receptor variant III); and a genetically-engineered antigen-presenting cells (APC)-based therapy, producing the T-cell attracting chemokine CXCL10 in the GL261-bearing mice

Guard Medical Reports Enrollment of the first 5 Patients in the Post-market Study of its NPseal™

“The first cases demonstrate fast application and easy activation of the NPsealTM” stated Machiel van der Leest, CEO of Guard Medical. “This ease of use combined with its cost effectiveness makes prophylactic use of NPWT for closed surgical wounds possible.” 

HistoSonics Announces First Patient Treated in European Clinical Trial

Otto von Guericke University Clinic Magdeburg is first to treat patient with liver tumors in company's #HOPE4LIVER Europe Study

2,000,000 TWO2 Treatments Milestone Reached as TWO2 Study Is Highlighted in Systemic Review of Topical Oxygen Therapies

“This is another enormous milestone for our company and a testament to the ease-of use and durable clinical efficacy of TWO2 therapy, as well as to the tenacity of our entire dedicated care team. AOTI

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Both patients were given access to Hemopurifier® treatment through Emergency Use. The manuscript is titled "Removal of COVID-19 Spike Protein, Whole Virus, Exosomes and Exosomal microRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients with COVID-19 Infection" and was published in Research Square.

IRRAS Announces Publication of a Case Report from Buffalo General Medical Center

IRRAflow Intraventricular Hemorrhage (IVH) Case Report Published in Cureus Journal of Medical Science. Publication also documents the ability to deliver targeted thrombolytic medication via IRRAflow's recurring irrigation for the first time in the peer-reviewed scientific literature

FAST BioMedical Successfully Completes Open-Label Proof-of-Concept Study for Measuring Interstitial Volume

Conducted at the Richard L. Roudebush VA Medical Center in Indianapolis, the study evaluated the safety, tolerability and performance of the FAST Technology in chronic dialysis patients with extremely reduced or no kidney function.